Dechra Pharmaceuticals (DPH) Pharma and Biotech Sector

  • Latest quote

    2,768.00p (mid)

  • Current Change (%)

    2.06%

  • Price

    Bid: 2,770.00p

    Offer: 2,774.00p

  • Today

    High: 2,778.00p

    Low: 2,722.00p

  • This year

    High: 2,858.00p

    Low: 1,647.00p

  • Information

    Volume: 98,144

    Market Cap: £2829.48M


Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Dechra Pharmaceuticals RNS Feed

Title Release date
Blocklisting 11:17 - June 4, 2018
Total Voting Rights 10:05 - April 30, 2018
Total Voting Rights 09:47 - April 3, 2018
Additional Listing 10:46 - March 15, 2018
Block listing six monthly return 07:00 - March 15, 2018
Director/PDMR Shareholding 10:58 - March 5, 2018
Director/PDMR Shareholding 09:40 - March 5, 2018
Director/PDMR Shareholding 14:16 - February 27, 2018
Director/PDMR Shareholding 15:50 - February 26, 2018
Half-Yearly Financial Report 2018 07:00 - February 26, 2018
Total Voting Rights 09:56 - February 14, 2018
Completion of Acquisition 15:59 - February 13, 2018
Result of General Meeting - 12 February 2018 09:51 - February 12, 2018
Notification of Major Holdings 13:33 - January 31, 2018
Holding(s) in Company 16:10 - January 30, 2018

NOTE: This is based on 22 open tips for this company


Total Number of Share tips :

29

View all Dechra Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today